Pfizer is launching Detrol follow-on Toviaz with a 12-week patient support program featuring a progress tracker, personalized emails and tips on bladder training techniques. The company said many overactive bladder patients currently suffer from a lack of behavioral intervention.
Non-compliance, requests for generics on the rise, says survey
Physicians say patient compliance is getting worse, and they’re hearing more requests for generic or OTC alternatives to prescribed medications as the economic malaise takes its toll, according to a PriMed survey.
Saatchi & Saatchi Wellness won the US integrated marketing account for Durex following a four-way pitch. The assignment spans advertising, digital, retail and CRM and includes the launch of the new Bare condom.
DTC spend set to slide, loyalty cards up, says survey
Marketers anticipate substantial cuts in DTC spend in 2009, according to a Cegedim Dendrite survey in which 58% of respondents said they’d cut consumer ad spend this year. Last year 28% said they’d cut back on consumer advertising.
As patients scrimp, BMS ads offer to pay Orencia co-pays
Recession got you down? Having second thoughts about filling that prescription? How about some help with your co-pay? That’s the tack Bristol-Myers Squibb is taking with its Orencia Promise program.
Nine months after it pulled Chantix DTC amid concern about possible psychiatric side effects, Pfizer’s tortoise and hare are back on the air with a new 90-second TV spot long on risk information.
To offer maximum returns, pharmaceutical Web sites and CRM programs must be designed and built using the insights from the user experience, say Laura Keller and Mark McConaghy
The internet hasn’t replaced traditional direct marketing, but its unique abilities have made it an essential part of the pharma marketing mix. Stephen McGuire finds out what Web-shy brand directors are missing
Centrix Pharmaceutical has agreed to license and deploy Cegedim North America’s Target SFA customer relationship management suite for its US sales force.